METABICAL CASE STUDY REPORT INTRODUCTION Excess weight had become a big crisis in the US, affecting about 65% of the adult population leading to different kinds of health complications. In the past, several manufacturers had introduced various weight loss products like over-the-counter (OTC) drugs, herbal products, supplementary fad diets, etc. All of these have proven to be unsuccessful because of their ineffectiveness, severe side effects and lack of credibility among consumers. At this juncture
Words: 4420 - Pages: 18
------------------------------------------------- 1. ¿Cómo se compara Metabical con las actuales opciones de pérdida de peso? Es un medicamento por prescripción médica que se concentra en un nicho de mercado, que son las personas que quieren perder peso en forma moderada. No está prometiendo que atacara la obesidad se enfoca en tratar desordenes metabólicos. Además está ofreciendo ser el medicamento que validada por la FDA y ocasiones daños o efectos secundarios pequeños, y no está dirigido en
Words: 1473 - Pages: 6
METABICAL Situational Analysis and SWOT Situational Analysis Item | Issues-Facts | Implications to Situation | SWOT | Organization Structure | | | | 1 | Barbara Printup has over 20 years of experience marketing prescription drugs | Experience helps in the marketing and launch strategy for s new product to market | S | Leadership | | | | 1 | $25B in sales in 2007 | Brand recognition is key | S | 2 | Clinical trials performed to show majority of individuals reached weight-loss
Words: 2469 - Pages: 10
Metabical : Positioning and Communication Strategy for a new Weight-Loss Drug ZOOM Syndicate Gari Nurahman Wahyu Kumoro Santo Rizal Background Time February 2008 Cambridge Sciences Pharmaceuticals (CSP) International health care company Focus on Developing, manufacturing, and marketing product (metabolic disorder, gastrointestinal disease, immune deficiencies, etc.) Barbara Printup, Senior Director of marketing Want to launch Metabical (Meh-tuh-bye-cal) Objective
Words: 1774 - Pages: 8
Metabical: Pricing, Packaging &Demand Forecasting For A New Weight Loss Drug Metabical: Pricing, Packaging &Demand Forecasting For A New Weight Loss Drug Abstract Metabical will be the only weight loss drug clinically proven to be effective for moderately overweight people, also recognized by the FDA. The CSP’s (Cambridge Sciences Pharmaceuticals) drug Metabical got its final approval from the FDA. The senior marketing director for CSP-Barbara Printup must develop the marketing communication
Words: 671 - Pages: 3
Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug 1- Discuss Metabical’s points of differentiation compared to current weight-loss options? After 10 years of testing and spending a significant amount in research and development. Cambridge Sciences Pharmaceuticals (CSP) discovered one of the best weight- loss drug that called Metabical. Metabical has unique characteristics that make it different in market. People are always concerned about the side effect
Words: 3129 - Pages: 13
A Case Write Up – Metabical Case Q1. Upon careful analysis of the case study we can summarise the current standing of the Metabical as a snapshot using the 5 Cs before deep-diving into the specific questions posed as follows: A. CUSTOMER: Metabical is a unique prescribed drug for overweight individuals with a BMI of 25 to 30. Essentially this group makes for our customers and consumers. More details of the target segment will follow as we discuss the case B. COMPANY:
Words: 252 - Pages: 2
pricing the Metabical at $150 for 1 months supply, with this price Metabical will be able to achieve their objective to enter $ 3.74 billion market for weight control products in the United states and more than 5% ROI within 5 years. For ROI refer (Ex-8(a)(b)(c)(d)) and for pricing and Economic Value Analysis (Ex 7). This recommendation is based on the economic value comparison against other competitors such as Alli and OTC Orlistat. In addition to selling a monthly supply of Metabical for $150, we
Words: 594 - Pages: 3
decisions: Company CSP is international healthcare company that develops, manufactures and markets products for treating metabolic disorders, gastrointestinal diseases, immune deficiencies and other chronic and medical conditions. CSP's Metabical would be the first prescription drug approved specifically for overweight individuals (BMI 25 to 30). According to CSP R&D team, this product is far more superior comparing to other weight loss prescribed medicines, due to its low dose active ingredients
Words: 278 - Pages: 2
Answer 1 - Each customer will need to answer the following questions: 1. Am I obese . One needs to analyze BMI data for finding an answer to this. 2. Do I want to change The answer to this question depends upon the following criteria. 1. Looks consciousness 2. Health consciousness 3. If the answer to both the above questions is yes then there will be 3 options for the customer for Exercise | OTC | Prescribed drugs | Pros1. Healthy@ naturalGood habitLifestyleCons:Time consuming
Words: 701 - Pages: 3
